Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.

Rouet R, Dudgeon K, Christie M, Langley D, Christ D.

J Biol Chem. 2015 May 8;290(19):11905-17. doi: 10.1074/jbc.M114.614842. Epub 2015 Mar 3.

2.

Identification of aggregation inhibitors of the human antibody light chain repertoire by phage display.

Swift J, Saing S, Rouet R, Dudgeon K, Schofield P, Sewell W, Christ D.

Protein Eng Des Sel. 2014 Oct;27(10):405-9. doi: 10.1093/protein/gzu026. Epub 2014 Jul 22.

PMID:
25053818
3.

Performing a breach risk assessment.

Beckett B, Burgess SD, Comfort A, DeMasters D, Dooling J, Fergen A, Gorton ER, Kadlec L, Kruse M, Mangin W, Dudgeon KT.

J AHIMA. 2013 Sep;84(9):66-70. No abstract available.

PMID:
24059159
4.

Rapid prediction of expression and refolding yields using phage display.

Dudgeon K, Rouet R, Christ D.

Protein Eng Des Sel. 2013 Oct;26(10):671-4. doi: 10.1093/protein/gzt019. Epub 2013 May 19.

PMID:
23690626
5.

Generation of human single domain antibody repertoires by Kunkel mutagenesis.

Rouet R, Dudgeon K, Christ D.

Methods Mol Biol. 2012;907:195-209. doi: 10.1007/978-1-61779-974-7_10.

PMID:
22907352
6.

Selection of human VH single domains with improved biophysical properties by phage display.

Dudgeon K, Rouet R, Famm K, Christ D.

Methods Mol Biol. 2012;911:383-97. doi: 10.1007/978-1-61779-968-6_23.

PMID:
22886264
7.

General strategy for the generation of human antibody variable domains with increased aggregation resistance.

Dudgeon K, Rouet R, Kokmeijer I, Schofield P, Stolp J, Langley D, Stock D, Christ D.

Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10879-84. doi: 10.1073/pnas.1202866109. Epub 2012 Jun 27.

8.

Expression of high-affinity human antibody fragments in bacteria.

Rouet R, Lowe D, Dudgeon K, Roome B, Schofield P, Langley D, Andrews J, Whitfeld P, Jermutus L, Christ D.

Nat Protoc. 2012 Feb 2;7(2):364-73. doi: 10.1038/nprot.2011.448.

PMID:
22301775
9.

Aggregation, stability, and formulation of human antibody therapeutics.

Lowe D, Dudgeon K, Rouet R, Schofield P, Jermutus L, Christ D.

Adv Protein Chem Struct Biol. 2011;84:41-61. doi: 10.1016/B978-0-12-386483-3.00004-5. Review.

PMID:
21846562
10.

Sequence determinants of protein aggregation in human VH domains.

Dudgeon K, Famm K, Christ D.

Protein Eng Des Sel. 2009 Mar;22(3):217-20. doi: 10.1093/protein/gzn059. Epub 2008 Oct 28.

PMID:
18957405
11.

KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.

Marreiros A, Dudgeon K, Dao V, Grimm MO, Czolij R, Crossley M, Jackson P.

Oncogene. 2005 Jan 20;24(4):637-49.

PMID:
15580298
12.

Physical exercise and psychological well being: a critical review.

Scully D, Kremer J, Meade MM, Graham R, Dudgeon K.

Br J Sports Med. 1998 Jun;32(2):111-20. Review.

13.

Pharmacological characterization of lithium reabsorption in the rat.

Steele TH, Dudgeon KL, Larmore CK.

J Pharmacol Exp Ther. 1976 Jan;196(1):188-93.

PMID:
1246010
14.

Phosphatemic action of 1,25-dihydroxyvitamin D3.

Steele TH, Engle JE, Tanaka Y, Lorenc RS, Dudgeon KL, DeLuca HF.

Am J Physiol. 1975 Aug;229(2):489-95.

PMID:
1163676
15.

Reabsorption of lithium and phosphate by the rat kidney: role of the parathyroids.

Steele TH, Dudgeon KL.

Kidney Int. 1974 Mar;5(3):196-203. No abstract available.

16.

Urate excretion and urine flow in a lithium-induced diabetes insipidus rat model.

Steele TH, Underwood JL, Dudgeon KL.

Pflugers Arch. 1974;346(3):205-13. No abstract available.

PMID:
4856414

Supplemental Content

Loading ...
Support Center